GovChime
AWARDDELIVERY ORDERSmall business

Delivery order 75F40120F19002EAGLE HEALTH, LLC

Overview

Award facts

Net obligations
$10.86M
$10,856,214of $10.86M potential value
Outlays (paid to date)
$5.25M
$5.25M paid of $10.86M obligated$5,252,161
Period of performance
Feb 28, 2020 to Mar 1, 2023
Ended
Modifications
9
Latest action Mar 18, 2026
Contract type
Delivery order
PIID 75F40120F19002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES

Dates and value

Award date
Signed on Feb 28, 2020
Potential end of performance
Mar 17, 2026
Current value
$10,856,214Base and exercised options
Potential value (if all options are exercised)
$10,856,214
Parent contract vehicle
75F40119D10029 (IDC, single award) — 3 orders recorded under it

Obligations by fiscal year of action

  • FY2022: $4,239,705
  • FY2021: $3,981,549
  • FY2020: $2,634,960

Total across 3 fiscal years: $10,856,214

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 18, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameEAGLE HEALTH, LLC
LocationMANASSAS, VA
UEIK7MPSQUS6XC3
CAGE code7QKR1
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCAPE FOX CORPORATION

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessSBA 8(a) program participantAlaska Native Corporation ownedFor-profit organizationLimited liability companyCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Fda other rent and rent related activities (including white oak consolidation); Coronavirus emergency funding supplemental; Fda user fees (non general fund); Fda working capital fundProgram activities075-0600, 075-4613Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
621498ALL OTHER OUTPATIENT CARE CENTERS
Product or service (PSC)
Q201MEDICAL- MANAGED HEALTHCARE (service)

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
Not reported
Contract pricing
Time and materialsY

Solicitation and notices

Solicitation ID
RFTOP 1225323(as reported)
Solicitation date
Feb 25, 2020

Contract details

Subcontracting plan
Plan not requiredB
Certified cost or pricing data
Yes
Service Contract Act labor standards
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction uses GFE/GFPY
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
Yes - service where PBA is used.Y

Transaction history

Modification history

Base award
Feb 28, 2020Base obligation at award: $2,300,174
Latest action
Mar 18, 2026 — Other administrative actionModification P00009; administrative: no change in scope or value
Latest substantive action
May 17, 2022 — Supplemental agreement (within scope)Modification P00007
Actions by type
  • Base award1
  • Other administrative action6
  • Option exercised2
  • Supplemental agreement (within scope)1
10 actions recorded, Feb 28, 2020 to Mar 18, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-X-0600-000
  • 075-X-4613-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$334,786
COVID-19 supplemental outlays
$192,758